Skip to main content
SpringerLink
Log in

Neuropeptide Y and sympathetic control of vascular tone in hypertension

  • Chapter
NPY Family of Peptides in Neurobiology, Cardiovascular and Metabolic Disorders: from Genes to Therapeutics

Part of the book series: Experientia Supplementum ((EXS,volume 95))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Morris JL, Bibbins IL (1992) Co-transmission and neuromodulation. In: J Burnstoc, CHV Hoyle (eds): Autonomic Neuroeffector Mechanisms. Harwood Academic Publisher, Reading UK, 33–119

    Google Scholar 

  2. White TD (1991) Role of ATP and adenosine in the autonomic nervous system, In: C Bell (ed.): Novel Perpheral Neurotransmitters. Pergamon Press, 9–64

    Google Scholar 

  3. Potter E (1991) Neuropeptide Y as an autonomic transmitter, In: C Bell (ed.): Novel Perpheral Neurotransmitters. Pergamon Press, 81–112

    Google Scholar 

  4. Lundberg JM (1996) Pharmacology of cotransmission in the autonomic nervous system: Integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol Rev 48: 113–178

    CAS  PubMed  Google Scholar 

  5. Westfall TC (2004) Prejunctional effects of neuropeptide Y and its role as a cotransmitter. Handbook of Exp Pharmacol 164: 138–183

    Google Scholar 

  6. Goldstein DS (1983) Plasma catecholamines and essential hypertension: An analytical review. Hypertension 5: 86–89

    CAS  PubMed  Google Scholar 

  7. Anderson EA, Lawton AL (1989) Elevated sympathetic nerve activity in borderline hypertensive humans: evidence from direct intraneural recordings. Hypertension 14: 177–183

    CAS  PubMed  Google Scholar 

  8. Esler M, Jennings G, Korner P, Willett I, Dudley F, Hasking G, Anderson W, Lambert G (1988) Assessment of human sympathetic nervous system activity from measurement of norepinephrine turnover. Hypertension 11: 3–20

    CAS  PubMed  Google Scholar 

  9. Westfall TC, Meldrum MJ (1985) Alterations in the release of norepinephrine at the vascular neuroeffector junction in hypertension. Ann Rev Pharmacol Tox 25: 621–641

    CAS  Google Scholar 

  10. deChamplain J (1990) Pre-and postsynaptic adrenergic dysfunctions in hypertension. J Hyperten Suppl 8: S77–S85

    CAS  Google Scholar 

  11. Lohmeier TE (2001) The sympathetic nervous system and long term blood pressure regulation. Am J Hypertension 14: 1475–1545

    Article  Google Scholar 

  12. Esler M (1995) Sympathetic nervous system: contribution to human hypertension and related cardiovascular disease. J Cardiovas Pharmacol 26Suppl (2): S24–S28

    CAS  Google Scholar 

  13. Grisk O, Kloting I, Exner J, Spiess S, Schmidt R, Junghans D et al. (2002) Long term arterial pressure in spontaneously hypertensive rats is set by the kidney. J Hyperten 20: 131–138

    CAS  Google Scholar 

  14. Ito S, Komatsu K, Tsukamoto K, Sved AF (2000) Excitatory amino acids in the rostral ventrolateral medulla support blood pressure in spontaneously hypertensive rats. Hypertension 35: 413–417

    CAS  PubMed  Google Scholar 

  15. Colombari E, Sato MA, Cravo SL, Bergamaschi CT, Campos RR Jr, Lopes OU (2001) Role of the medulla oblongata in hypertension. Hypertension 38: 549–554

    CAS  PubMed  Google Scholar 

  16. Kubo T, Fukumorl R, Kobayashi M, Yamaguchi H (1998) Evidence suggesting that lateral parabrachial nucleus is responsible for enhanced medullary cholinergic activity in hypertension. Hypertension Res 21: 201–207

    CAS  Google Scholar 

  17. Michel MC, Rascher W (1995) Neuropeptide Y: a possible role in hypertension? J Hyperten 13: 385–395

    CAS  Google Scholar 

  18. Pedrazzini T, Pralong F, Grouzmann E (2003) Neuropeptide Y: the universal soldier. Cell Molecular Life Sci 60: 350–377

    CAS  Google Scholar 

  19. Egan BM (2003) Insulin resistance and the sympathetic nervous system. Current Hyperten Reports 5: 247–254

    Google Scholar 

  20. Pons J, Lee EW, Li L, Kitlinska J (2004) Neuropeptide Y: Multiple receptors and multiple roles in cardiovascular diseases. Curr Op Invest Drugs 5: 957–962

    CAS  Google Scholar 

  21. Zukowska Z, Pons J, Lee EW, Li L (2003) Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system. Can J Physiol Pharmacol 81: 89–94

    Article  CAS  PubMed  Google Scholar 

  22. Morris MJ (2004) Neuropeptide Y and cardiovascular function. Handbook Exp Pharmacol 162: 328–359

    Google Scholar 

  23. Dhital KK, Gerli R, Lincoln J, Milner P, Tanganeu P, Weber G, Fruschelli C, Burnstock E (1988) Increased density of perivascular nerves to the major cerebral vessels of the spontaneously hypertensive rat: differential changes in noradrenaline and neuropeptide Y during development. Brain Res 444: 33–45

    CAS  PubMed  Google Scholar 

  24. Kawamura K, Takebayashi S (1991) Perivascular innervation of the cerebral arteries in Spontaneously Hypertensive Rats — an immunohistochemical study. Angiology 42: 123–132

    CAS  PubMed  Google Scholar 

  25. Lee RM, Nagahama M, McKenzie R, Daniel EE (1988) Peptide containing nerves around blood vessels of stroke-prone spontaneously hypertensive rats. Hypertension 11: I117–I120

    CAS  PubMed  Google Scholar 

  26. Kawamura K, Ando K, Takebayashi S (1989) Perivascular innervation of the mesenteric artery in spontaneously hypertensive rats. Hypertension 14: 660–665

    CAS  PubMed  Google Scholar 

  27. Gradin K, Li J-Y, Anderson O, Simonsen A (2003) Enhance neuropeptide Y immunoreactivity and vasoconstriction in mesenteric small arteries from spontaneously hypertensive rats. J Vas Res 40: 252–265

    CAS  Google Scholar 

  28. Fan X-M, Hendley ED, Forehand CJ (1995) Enhanced vascular neuropeptide Y — immunoreactive innervation in two hypertensive rat strains. Hypertension 26: 758–763

    CAS  PubMed  Google Scholar 

  29. Fujimoto C, Ito M, Sekine I (1993) Noradrenergic and neuropeptide Y — immunoreactive nerves in the pancreatic islets of spontaneously hypertensive rats. Regul Pept 47: 171–178

    Article  CAS  PubMed  Google Scholar 

  30. Clark JT, Sahu A, Mrotek J, Kalra S (1991) Sexual function and neuropeptide Y levels in selected brain regions in male spontaneously hypertensive rats. Am J Physiol 261: R1234–R1241

    CAS  PubMed  Google Scholar 

  31. Louis WJ, Howes CLG, Maccarrone L, Beart PM, Jarrott B (1987) Neurotransmitters and neuropeptides in blood pressure regulation in the spontaneously hypertensive rat. Can J Physiol Pharmacol 65: 1633–1637

    CAS  PubMed  Google Scholar 

  32. Tong Y-C, Hung Y-C, Lin S-N, Cheng J-T (1996) The norepinephrine tissue concentration and neuropeptide Y immunoreactivity in genitourinary organs of the spontaneously hypertensive rat. J Autonom Nerv Sys 56: 215–218

    CAS  Google Scholar 

  33. Maccarrone C, Jarrott B (1986) Age related changes in neuropeptide Y immunoreactivity in the cortex and spinal cord of spontaneously hypertensive and normotensive Wistar-Kyoto rats. J Hyperten 4: 471–475

    CAS  Google Scholar 

  34. Jarrott B, Lewis SJ, Maccarrone C, Shulkes A (1988) Altered levels of neuropeptides in the medulla and spinal cord of spontaneously hypertensive rats. Clin Exp Pharm Physiol 15: 157–162

    CAS  Google Scholar 

  35. Corder R (2000) Effect of lisinopril on tissue levels of neuropeptide Y in normotensive and spontaneously hypertensive rats. J Human Hyperten 14: 381–384

    CAS  Google Scholar 

  36. Ballesta J, Lawson JA, Pals DT, Ludens JH, Lee YC, Bloom SR, Polak JM (1987) Significant depletion of NPY in the innervation of the rat mesenteric, renal arteries and kidneys in experimentally (aorta coarctation) induced hypertension. Histochem 87: 273–278

    Article  CAS  Google Scholar 

  37. Haefliger JA, Waeber B, Grouzmann E, Braissant O, Nussberger J, Nicol P, Waeber G (1999) Cellular localization expression and regulation of neuropeptide Y in kidneys of hypertensive rats. Regul Pept 82: 35–43

    Article  CAS  PubMed  Google Scholar 

  38. Tabarin A, Minot AP, Dallochio M, Roger P, Ducassou D (1992) Plasma concentration of neuropeptide Y in patients with adrenal hypertension. Regul Pept 42: 51–61

    Article  CAS  PubMed  Google Scholar 

  39. Veglio F, Schiavone D, Mengozzi G, Molino P, Chiandussi L (1995) Levels of plasma neuropeptide Y and other vasoactive substances during head up tilt in normal and essential hypertensive subjects. Clin Auton Res 5: 67–70

    Article  CAS  PubMed  Google Scholar 

  40. Erlinge O, Ekman R, Thulin T, Edvinsson L (1992) Neuropeptide Y-like immunorreactivity and hypertension. J Hyperten 10: 1221–1225

    CAS  Google Scholar 

  41. Lettgen B, Wagner S, Hanze J, Lang RE, Rascher W (1994) Elevated plasma concentration of neuropeptide Y in adolescents with primary hypertension. J Human Hyperten 8: 345–349

    CAS  Google Scholar 

  42. Wocial B, Ignatowska-Switalska H, Pruszczyk P, Jedrusik P, Januszewicz A, Lapinski M, Januszewicz W, Zukowska-Grojec Z (1995) Plasma neuropeptide Y and catecholamines in women and men with essential hypertension. Blood Pres 4: 143–147

    CAS  Google Scholar 

  43. Chalmers J, Morris M, Kapoor V, Cain M, Elliott J, Russell A, Pilowsky P, Minson J, West M, Wing L (1989) Neuropeptide Y in the sympathetic control of blood pressure in hypertensive subjects. Exp Hypertension-Part A, Theo and Practice 11(Suppl) 59–66

    Google Scholar 

  44. Berent H, Kuczynska K, Kochmanski M, Wocial B, Lapinski M, Lewandowski J, Januszewicz A, Ignatowska-Switalska H, Januszewicz W (1997) Hemorrhaeological indices, catecholamines neuropeptide Y and serolonia in patients with essential hypertension. Blood Pressure 6: 203–208

    CAS  PubMed  Google Scholar 

  45. Solt VB, Brown MR, Kennedy B, Kolterman O, Ziegler MG (1990) Elevated insulin, norepinephrine and neuropeptide Y in hypertension. Am J Hyperten 3: 823–828

    CAS  Google Scholar 

  46. Edvinsson L, Ekman R, Thulin T (1991) Increased plasma levels of neuropeptide Y-like immunoreactivity and catecholamines in severe hypertension remain after treatment of normotension in man. Regul Pept 32: 279–287

    Article  CAS  PubMed  Google Scholar 

  47. Takahashi K, Mouri T, Itoi K, Soni M, Ohneda M, Murakami O, Nozuki M, Tachibana Y, Yoshinaga K (1987) Increased plasma immunoreactive neuropeptide Y concentrations in phaeochromocytoma and chronic renal failure. J Hyperten 5: 749–753

    CAS  Google Scholar 

  48. Gröndal S, Eriksson B, Hamberger B, Theodorsson E (1991) Plasma chromogranin A + B, neuropeptide Y and catecholamines in pheochromocytoma patients. J Intern Med 229: 453–456

    PubMed  Google Scholar 

  49. Grouzman E, Comoy E, Bouhon C (1989) Plasma neuropeptide Y concentrations in patients with neuroendocrine tomours. J Clin Endo Metab 68: 808–813

    Google Scholar 

  50. Puybasset L, Lacolley P, Laurent S, Mignon F, Billaud E, Cuche J-L, Comoy E, Safar M (1993) Effects of clonidine on plasma catecholamines and neuropeptide Y in hypertensive patients at rest and during stress. J Cardiovas Pharmacol 21: 912–919

    CAS  Google Scholar 

  51. Pruszczyk P, Chlebus M (1995) Plasma neuropeptide Y during dynamic exercise in patients with essential hypertension. Clin Exper Hyperten 17: 769–785

    CAS  Google Scholar 

  52. Böhm M, Gräbel C, Knorr A, Erdmann E (1995) Treatment in hypertensive cardiac hypertrophy, I neuropeptide Y and β-adrenoceptors. Hyperten 25: 954–961

    Google Scholar 

  53. Zukowska-Grojec Z, Wahlestedt C (1993) Origin and actions of neuropeptide Y in the cardiovascular systems. In: The Biology of Neuropeptide Y and Related Peptides. Colmers WF, Wahlestedt C (Eds), Humana Press, 315–388

    Google Scholar 

  54. Ogawa T, Kitamura K, Kangawa K, Matsuo H, Eto T (1992) Platelet neuropeptide Y in spontaneously hypertensive rats. J Hyperten 10: 765–771

    CAS  Google Scholar 

  55. Ogawa T, Kitamura K, Kawamoto M, Eto T, Tanaka K (1989) Increased immunoreactive neuropeptide Y in platelets of SHR. Biochem Biophy Res Comm 165: 1399–1405

    CAS  Google Scholar 

  56. Chen S-H, Han Q-D (1995) Increase of release of neuropeptide Y in vitro from platelets of spontaneously hypertensive rats. Acta Pharmacol Sinica 16: 149–152

    CAS  Google Scholar 

  57. Howe PRC, Rogers PF, Morris MJ, Chalmers JP, Smith RM (1986) Plasma catecholamines and neuropeptide Y as indices of sympathetic nerve activity in normotensive and stroke-prone spontaneously hypertensive rats. J Cardiovas Pharmacol 8: 1113–1121

    CAS  Google Scholar 

  58. Moreau P, deChamplain J, Yamaguchi N (1992) Alterations in circulating levels and cardiovascular tissue content of neuropeptide Y-like immunoreactivity during the development of deoxycorticosterone acetate-salt hypertension in the rat. J Hyperten 10: 773–780

    CAS  Google Scholar 

  59. Minson RB, McRitchie RJ, Morrison J, Chalmers JP (1990) Effects of neuropeptide Y on cardiac performance and renal blood flow in conscious normotensive and renal hypertensive rabbits. Clin Exp Hyperten, Part A, Theo and Practice 12: 267–284

    CAS  Google Scholar 

  60. Miller DW, Tessel RE (1991) Age dependent hyperresponsiveness of spontaneously hypertensive rats to the pressor effects of intravenous neuropeptide Y: Role of mode of peptide administration and plasma NPY-like immunoreactivity. J Cardiovas Pharmacol 18: 647–656

    CAS  Google Scholar 

  61. Zukowska-Grojec Z, Golczynska M, Shen GH, Torres-Duarte A, Haass M, Wahlestedt C, Myers AK (1993) Modulation of vascular function by neuropeptide Y during development of hypertension in spontaneously hypertensive rats. Pediatr Nephrol 7: 845–852

    Article  CAS  PubMed  Google Scholar 

  62. Westfall TC, Martin J, Chen X, Ciarleglio A, Carpentier S, Henderson K, Knuepfer M, Beinfeld M, Naes L (1988) Cardiovascular effects and modulation of noradrenergic neurotransmission following central and peripheral administration of neuropeptide Y. Synapse 2: 299–307

    Article  CAS  PubMed  Google Scholar 

  63. Westfall TC, Han S-P, Chen X, Del Valle K, Curfman M, Ciarleglio A, Naes L (1990) Presynaptic peptide receptors and hypertension. Ann NY Acad Sci 604: 372–388

    CAS  PubMed  Google Scholar 

  64. Westfall TC, Han S-P, Knuepfer M, Martin J, Chen X, Del Valle K, Ciarleglio A, Naes L (1990) Neuropeptides in hypertension: Role of neuropeptide Y and calcitonin gene related peptide. Br J Clin Pharma 30: 75S–82S

    CAS  Google Scholar 

  65. Westfall TC (1995) Beneficial therapeutic interventions via manipulation of presynaptic modulatory mechanism. In: Neurotransmitter Release and Its Modulation. Powis D, Bonn S (Eds), Cambridge University Press, 17: 328–346

    Google Scholar 

  66. McAuley M, Chen X, Westfall TC (1993) Central cardiovascular actions of neuropeptide Y. In: The Biology of Neuropeptide Y and Related Peptides. Colmers WF, Wahlestedt C (Eds), Humana Press, Totowa, NJ, 389–418

    Google Scholar 

  67. Aguirre JA, Hedlund PB, Narváez JA, Bunnemann B, Ganten D, Fuxe K (1995) Increased vasopressor actions of intraventricular neuropeptide Y 13-36 in spontaneous hypertensive versus normotensive Wistar-Kyoto rats. Possible relationship to increases in Y2 receptor binding in the nucleus tractus solitarius. Brain Res 684: 159–164

    Article  CAS  PubMed  Google Scholar 

  68. Coelho EF, Ferrari MFR, Maximino JR, Fior-Chadi DR (2004) Change in the expression of NPY receptor subtypes Y1 and Y2 in central and peripheral neurons related to the control of blood pressure in rats following experimental hypertension. Neuropept 38: 77–82

    CAS  Google Scholar 

  69. Chen X, Henderson K, Beinfeld MD, Westfall TC (1988) Alterations in blood pressure of normotensive and hypertensive rats following intrathecal injections of neuropeptide Y. J Cardiovas Pharmacol 12: 473–478

    CAS  Google Scholar 

  70. Chen X, Knuepfer MM, Westfall TC (1990) Hemodynamic and sympathetic effects of spinal administration of neuropeptide Y in rats. Am J Physiol (Heart Circ Physiol) 259: 1674–1680

    Google Scholar 

  71. Chen X, Westfall TC (1993) The depressor effect of intrathecal NPY is mediated by Y2 subtype of NPY receptors. J Cardiovas Pharmacol 21: 720–724

    CAS  Google Scholar 

  72. Takesako T, Takeda K, Kuwahara T, Takenaka K, Tanaka M, Itoh H, Nakata T, Sasaki S, Nakagawa M (1994) Alterations of response to neuropeptide Y in the nucleus tractus solitarius of spontaneously hypertensive rats. Hypertension 23(Supp I) I93–I96

    CAS  PubMed  Google Scholar 

  73. Malmstrom RE, Lundberg JM (1995) Endogenous NPY acting on the Y1 receptor accounts for the long lasting part of the sympathetic contraction in guinea pig vena cava: evidence using SR 120107A. Acta Physiol Scand 155: 329–330

    CAS  PubMed  Google Scholar 

  74. Lundberg JM, Modin A (1995) Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y′ receptor antagonist. BIBP 3226. Br J Pharmacol 116: 2971–2982

    CAS  PubMed  Google Scholar 

  75. Malmstrom RE, Lundberg JM (1995) Neuropeptide Y accounts for sympathetic vasoconstriction in guinea pig vena cava: evidence using BIBP 3226 and 3435. Eur J Pharmacol 294: 661–668

    Article  CAS  PubMed  Google Scholar 

  76. Han S-P, Yang CL, Chen X, Naes L, Cox BF, Westfall TC (1998) Direct evidence for the role of neuropeptide Y in sympathetic nerve stimulation induced vasoconstriction. Am J Physiol 274 (Heart Circ Physiol 43 H290–H295

    CAS  PubMed  Google Scholar 

  77. Daly RN, Roberts MI, Ruffolo RR Jr, Hieble JP (1988) The role of neuropeptide Y in vascular sympathetic neurotransmission may be enhanced in hypertension. J Hyperten 6(Supp 6) S535–S538

    CAS  Google Scholar 

  78. Mezzano V, Donoso V, Capurro D, Huidobro-Toro JP (1998) Increased neuropeptide Y pressor activity in Goldbatt Hypertensive Rats: In vivo studies with BIBP 3226 peptides 19: 1227–1232

    CAS  Google Scholar 

  79. Zhao X-H, Sun X-Y, Edvinsson L, Hedner T (1997) Does the neuropeptide Y-Y1: receptor contribute to blood pressure control in the spontaneously hypertensive rat? J Hyperten 15: 19–27

    CAS  Google Scholar 

  80. Shin LH, Dovgan PS, Nypaver TJ, Carretero O, Beierwaltes WH (2000) Role of neuropeptide Y in the development of two-kidney, one-clip renovascular hypertension in the rat. J Vasc Surg 32: 1015–1021

    Article  CAS  PubMed  Google Scholar 

  81. Doods HN, Wienen W, Entzeroth M, Rudolf K, Eberlein W, Engel W, Wieland HA (1995) Pharamcological characterization of the selective nonpeptide Y Y1 receptor antagonist BIBP 3226. J Pharmacol Exp Ther 275: 136–142

    CAS  PubMed  Google Scholar 

  82. Tsuda K, Tsuda S, Masuyama Y, Goldstein M (1990) Norepinephrine release and neuropeptide Y in medulla oblongata of spontaneously hypertensive rats. Hypertension 15: 784–790

    CAS  PubMed  Google Scholar 

  83. Tsuda K, Tsuda S, Goldstein M, Masuyama Y (1990) Effects of neuropeptide Y on norepinephrine release in hypothalamic slices of spontaneously hypertensive rats. Eur J Pharmacol 182: 175–179

    CAS  PubMed  Google Scholar 

  84. Tsuda K, Tsuda S, Goldstein M, Nishio I, Masuyama Y (1992) Modulation of noradrenergic transmission by neuropeptide Y and presynaptic α2-adrenergic receptors in the hypothalamus of spontaneously hypertensive rats. Jap Heart J 33: 229–238

    CAS  PubMed  Google Scholar 

  85. Qualy JM, Westfall TC (1993) Age-dependent overflow of endogenous norepinephrine from paraventricular hypothalamic nucleus of hypertensive rats. Am J Physiol 265 (Heart Circ Physiol 34): H39–H46

    CAS  PubMed  Google Scholar 

  86. Woo ND, Mukherjee K, Gangluly PK (1993) Norepinephrine levels in paraventricular nucleus of spontaneously hypertensive rats: role of neuropoeptide Y. Am J Physiol 265 (Heart Circ Physiol 34) H893–H898

    CAS  PubMed  Google Scholar 

  87. Katsuya T, Higaki J, Zhao Y, Miki T, Mikami H, Serikawa T, Ogihara T (1993) A neuropeptide Y locus on chromosome 4 cosegregates with blood pressure in the spontaneously hypertensive rat. Biochem Biophy Res Comm 192: 261–267

    CAS  Google Scholar 

  88. Baker E, Hort YJ, Ball H, Sutherland GR, Shine J, Herzog H (1995) Assignment of the human neuropeptide Y gene to chromosome 7p15.1 by nonisotopic in situ hybridization. Genomics 26: 163–164

    Article  CAS  PubMed  Google Scholar 

  89. Karvonen MK, Pesonen U, Koulu M, Niskanen L, Laakso M, Rissanen A et al. (1998) Association of a leucine (7)-to-proline (7) polymorphism on the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels. Nat Med 4: 1434–1437

    Article  CAS  PubMed  Google Scholar 

  90. Wallerstedt SM, Skrtic S, Eriksson A-L, Ohlsson C, Hedner T (2004) Association analysis of the polymorphism T1128C in the signal peptide of neuropeptide Y in a Swedish hypertensive population. J Hyperten 22: 1277–1281

    CAS  Google Scholar 

  91. Zhuo JL (2004) Neuropeptide Y T1128 C polymorphism: an independent predictor of hypertensive and cardiovascular diseases. J Hyperten 22: 1251–1253

    CAS  Google Scholar 

  92. Wilfried R, Grammer T, Hoffmann MM, Nauck MS, Winkelmann BR, Boehm BO, Marz W (2004) Association analysis of the polymorphism T 1128 C in the signal peptide of the neuropeptide Y in a Swedish hypertensive population. J Hyperten 22: 2398–2399

    Google Scholar 

  93. Wallerstedt SM, Hedner T (2004) Author reply to ref. 92. J Hyperten 22: 2399–2400

    CAS  Google Scholar 

  94. Unger T, Parati C (2005) Acute stress and long lasting blood pressure elevation: a possible cause of established hypertension. J Hyperten 23: 261–263

    CAS  Google Scholar 

  95. Folkow B (1990) Structural factor in primary and secondary hypertension. Hypertension 16: 89–101

    CAS  PubMed  Google Scholar 

  96. Zukowska-Grojec Z, Dayao EK, Karwatowska-Prokopczuk E, Hauser GJ, Doods HN (1996) Stress induced mesenteric vasoconstriction in rats is mediated by neuropeptide Y Y1 receptors. Am J Physiol 270 (Heart Circ Physiol 39) H796–H800

    CAS  PubMed  Google Scholar 

  97. Papanek PE, Wood CE, Fregly MJ (1991) Role of the sympathetic nervous system in cold-induced hypertension in rats. J Appl Physiol 71: 300–306

    CAS  PubMed  Google Scholar 

  98. Hatton DC, Demerritt J, Costesc C, McCarron DA (1993) Stress-induced hypertension in the borderline hypertensive rats: Stimulus parameters. Physiol Behav 54: 635–641

    Google Scholar 

  99. Han S-P, Chen X, Cox B, Yang C-L, Wu Y-M, Naes L, Westfall TC (1998) Role of neuropeptide Y in cold stress-induced hypertension. Pept 19: 351–558

    CAS  Google Scholar 

  100. Han SP, Chen X, Yang C-L, Vickery L, Wu Y, Naes L, Macarthur H, Westfall TC (2005) Influence of cold stress on neuropeptide Y and sympathetic neurotransmission. Pept Epub, June 29, 2005

    Google Scholar 

  101. Han SP, Chen X, Wu Y, Naes L, Westfall TC (1997) Elevated neuropeptide Y gene expression and release during hypoglycemic stress. Pept 18: 1335–1340

    CAS  Google Scholar 

  102. Zhang W, Lundberg JM, Thorén P (1997) Neuropeptide Y Y1 receptor antagonist BIBP3226 attenuates stress evoked tachycardia in conscious spontaneously hypertensive rats. Cardiovas Drugs Ther 11: 801–806

    CAS  Google Scholar 

  103. Odar-Cederlöf I, Ericsson F, Theodorsson E, Kjellstrand CM (1998) Is neuropeptide Y a contributor to volume-induced hypertension? Am J Kid Dis 31: 803–808

    PubMed  Google Scholar 

  104. Krukoff TL, Mactavish D, Jhamandas JH (1999) Effects of restraint stress and spontaneous hypertension on neuropeptide Y neurons in the brainstem and arcuate nucleus. J Neuroendocrin 11: 715–723

    CAS  Google Scholar 

  105. Sweerts BW, Jarrott B, Lawrence AJ (2001) The effect of acute and chronic restraint on the central expression of pre pro-neuropeptide Y mRNA in normotensive and hypertensive rats. J Neuroendocrin 13: 608–617

    CAS  Google Scholar 

  106. Pettersson-Fernhoml K, Karvonen MK, Kallio J, Forsblom CM, Koulu M, Personen U et al. (2004) Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with proteinuria, coronary heart disease, and glycemic control in type 1 diabetic patients. Diabetes Care 27: 503–509

    Google Scholar 

  107. Niskanen L, Voutilainen-Kaunisto R, Terasvirta M, Karvonen MK, Valve R, Pesonen U et al. (2000) Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with retinopathy in type 2 diabetes. Exp Clin Endocrinol Diabetes 108: 235–236

    Article  CAS  PubMed  Google Scholar 

  108. Niskanen LI, Karvonen MK, Valve R, Koulu M, Pesonen U, Mercuri M et al. (2000) Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with enhanced carotid atherosclerosis in elderly patients with type 2 diabetes and control subjects. J Clin Endocrinol Metab 85: 2266–2269

    Article  CAS  PubMed  Google Scholar 

  109. Karvonen MK, Valkonen VP, Lakka TA, Salonen R, Koulu M, Personen U et al. (2001) Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with the progression to carotid atherosclerosis, blood pressure and serum lipids in Finnish men. Atherosclerosis 159: 145–151

    Article  CAS  PubMed  Google Scholar 

  110. Erkkila AT, Lindi V, Lehto S, Laakso M, Uusitupa MI (2002) Association of leucine 7 to praline polymorphism in the preproneuropeptide Y with serum lipids in patients with coronary heart disease. Mol Genet Metab 75: 260–264

    Article  PubMed  Google Scholar 

  111. Yamada Y, Izawa H, Ichihara S, Takatsu F, Ishihara H, Hirayama H et al. (2002) Prediction of the risk of myocardial infarction from polymorphism in candidate genes. N Engl J Med 347: 1916–1923

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacological and Physiological Science, Saint Louis University, St. Louis, Missouri, USA

    Thomas C. Westfall

Authors
  1. Thomas C. Westfall
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Physiology and Biophysics, Georgetown University Medical Center, 3900 Reservoir Rd., NW, Washington, DC, 20057, USA

    Zofia Zukowska

  2. Wyeth Research, Building A3153, 500 Arcola Rd, Collegeville, PA, 19426, USA

    Giora Z. Feuerstein

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Birkhäuser Verlag/Switzerland

About this chapter

Cite this chapter

Westfall, T.C. (2006). Neuropeptide Y and sympathetic control of vascular tone in hypertension. In: Zukowska, Z., Feuerstein, G.Z. (eds) NPY Family of Peptides in Neurobiology, Cardiovascular and Metabolic Disorders: from Genes to Therapeutics. Experientia Supplementum, vol 95. Birkhäuser Basel. https://doi.org/10.1007/3-7643-7417-9_6

Download citation

Publish with us

Policies and ethics

Search

Navigation